Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Columbia University
M.D. Anderson Cancer Center
Virginia Commonwealth University